Coastwise Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
28,961
+470
+2% +$27K 0.97% 21
2026
Q1
$1.73M Buy
28,491
+70
+0.2% +$4.08K 0.96% 22
2025
Q4
$1.53M Sell
28,421
-1,804
-6% -$86.8K 0.77% 27
2025
Q3
$1.36M Buy
30,225
+4,540
+18% +$212K 0.96% 25
2025
Q2
$1.19M Buy
25,685
+1,595
+7% +$78.3K 0.95% 29
2025
Q1
$1.47M Sell
24,090
-2,600
-10% -$152K 1.24% 19
2024
Q4
$1.51M Sell
26,690
-2,849
-10% -$159K 1.21% 23
2024
Q3
$1.53M Sell
29,539
-6,216
-17% -$292K 1.26% 19
2024
Q2
$1.48M Buy
35,755
+15,234
+74% +$682K 1.41% 16
2024
Q1
$1.11M Buy
20,521
+4,417
+27% +$225K 1.03% 26
2023
Q4
$826K Sell
16,104
-6,668
-29% -$350K 0.84% 35
2023
Q3
$1.32M Buy
22,772
+2,321
+11% +$142K 1.51% 13
2023
Q2
$1.31M Buy
20,451
+1,895
+10% +$127K 1.48% 13
2023
Q1
$1.29M Sell
18,556
-561
-3% -$39.6K 1.47% 15
2022
Q4
$1.38M Buy
19,117
+738
+4% +$55.6K 1.63% 12
2022
Q3
$1.31M Sell
18,379
-714
-4% -$51.8K 2.06% 7
2022
Q2
$1.47M Sell
19,093
-1,034
-5% -$78.8K 1.79% 13
2022
Q1
$1.47M Buy
+20,127
New +$1.35M 1.83% 11

Other funds holding BMY

Coastwise Capital Group's BMY Position: Q2 2026 in Review

Coastwise Capital Group increased its Bristol-Myers Squibb (BMY) stake by 1.6% in Q2 2026, buying an estimated $27K and bringing the position to 28,961 shares worth $1.67M. The position accounts for 0.97% of the portfolio, ranked #21.

Coastwise Capital Group first reported a position in BMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.73M in Q1 2026. 885 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Coastwise Capital Group held 28,961 shares of Bristol-Myers Squibb worth $1.67M as of Q2 2026.
  • Coastwise Capital Group bought 470 Bristol-Myers Squibb shares in Q2 2026, an estimated $27K.
  • Bristol-Myers Squibb made up 0.97% of Coastwise Capital Group's portfolio in Q2 2026, its #21 holding.
  • Coastwise Capital Group first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 18 quarters since.
  • Coastwise Capital Group's Bristol-Myers Squibb position peaked at $1.73M in Q1 2026.
  • 885 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.